Interestingly, a peptide inhibiting RHOA activation by GEF-H1 has been shown to inhibit blood vessel leakage in a mouse model of uveitis (Mills et al., 2022), opening the door to a new therapeutic approach. This evidence concerns the gene ARHGEF2 and uveitis.